Masanori Kubo
Department of Clinical Research and Development
Otsuka Pharmaceutical Co Ltd
Osaka
Japan
Name/email consistency: high
- Pharmacokinetics of aripiprazole, a new antipsychotic, following oral dosing in healthy adult Japanese volunteers: influence of CYP2D6 polymorphism. Kubo, M., Koue, T., Maune, H., Fukuda, T., Azuma, J. Drug Metab. Pharmacokinet. (2007)
- Influence of itraconazole co-administration and CYP2D6 genotype on the pharmacokinetics of the new antipsychotic ARIPIPRAZOLE. Kubo, M., Koue, T., Inaba, A., Takeda, H., Maune, H., Fukuda, T., Azuma, J. Drug Metab. Pharmacokinet. (2005)
- Development and validation of an LC-MS/MS method for the quantitative determination of aripiprazole and its main metabolite, OPC-14857, in human plasma. Kubo, M., Mizooku, Y., Hirao, Y., Osumi, T. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. (2005)